- Together with Sorrento's previously announced potent STI-1499 neutralizing antibody preclinical product candidate, STI-4398 COVIDTRAP may provide a potent antidote against COVID-19. SAN DIEGO, June ...
SAN DIEGO, March 20, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced it has produced a preclinical batch of the STI-4398 (COVIDTRAP) protein to immediately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results